mifepristone has been researched along with Pancreatic Neoplasms in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellini, R; Biagioli, M; Bordoni, M; Catalanotti, B; Di Giorgio, C; Distrutti, E; Fiorucci, S; Lupia, A; Marchianò, S; Massa, C; Monti, MC; Moraca, F; Morretta, E; Roselli, R; Sepe, V; Urbani, G; Zampella, A | 1 |
| Aikins, JK; Check, D; Check, JH; Poretta, T; Srivastava, MD | 1 |
| Bunuales, M; German, B; Gonzalez-Aparicio, M; Hernandez-Alcoceba, R; Poutou, J; Zugasti, I | 1 |
| Felizola, SJ; Kasajima, A; Motoi, F; Nakamura, Y; Ogata, H; Onodera, Y; Sasano, H; Unno, M; Watanabe, M; Yazdani, S | 1 |
| Fabri, PJ; Godellas, CV; Gower, WR; Risch, RM | 1 |
| Check, D; Check, JH; Cohen, R; Dix, E; Wilson, C | 1 |
| Akusjärvi, G; Barbu, AR; Welsh, N | 1 |
| Kaiser, A; Riecken, EO; Rosewicz, S; Stier, U | 1 |
| Atouf, F; Czernichow, P; Polak, M; Scharfmann, R; Tazi, A | 1 |
| Arnold, R; Göke, B; Göke, R; Richter, G | 1 |
10 other study(ies) available for mifepristone and Pancreatic Neoplasms
| Article | Year |
|---|---|
Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma.
Topics: Adenocarcinoma; Carcinoma, Pancreatic Ductal; Drug Repositioning; Female; Hormone Antagonists; Humans; Mifepristone; Pancreatic Neoplasms; Pregnancy; Receptors, OSM-LIF | 2022 |
Treatment With Mifepristone Allows a Patient With End-stage Pancreatic Cancer in Hospice on a Morphine Drip to Restore a Decent Quality of Life.
Topics: Analgesics, Opioid; Hormone Antagonists; Humans; Male; Middle Aged; Mifepristone; Morphine; Pancreatic Neoplasms; Quality of Life; Survival Analysis | 2020 |
Adaptation of vectors and drug-inducible systems for controlled expression of transgenes in the tumor microenvironment.
Topics: Animals; Cell Line, Tumor; DNA-Binding Proteins; Female; Genetic Vectors; Humans; Interleukin-12; Mice, Inbred C57BL; Mifepristone; Pancreatic Neoplasms; Recombinant Fusion Proteins; Transcription Factors; Transgenes; Tumor Microenvironment | 2017 |
Progesterone Receptor Isoforms A and B in Pancreatic Neuroendocrine Tumor.
Topics: Antineoplastic Agents, Hormonal; Cell Line, Tumor; Cell Proliferation; Female; Hormone Antagonists; Hormones; Humans; Male; Middle Aged; Mifepristone; Neuroendocrine Tumors; Pancreatic Neoplasms; Progesterone; Protein Isoforms; Receptors, Progesterone | 2015 |
HPAC, a new human glucocorticoid-sensitive pancreatic ductal adenocarcinoma cell line.
Topics: Adenocarcinoma; Animals; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Dexamethasone; Dose-Response Relationship, Drug; Hormone Antagonists; Humans; Hydrocortisone; Insulin; Karyotype; Male; Mice, Inbred BALB C; Mice, Nude; Mifepristone; Pancreatic Neoplasms; Receptors, Glucocorticoid; Transforming Growth Factor alpha; Xenograft Model Antitumor Assays | 1994 |
Efficacy of the progesterone receptor antagonist mifepristone for palliative therapy of patients with a variety of advanced cancer types.
Topics: Adult; Aged; Carcinoma, Transitional Cell; Colonic Neoplasms; Female; Histiocytoma, Malignant Fibrous; Hormone Antagonists; Humans; Kidney Neoplasms; Leiomyosarcoma; Male; Middle Aged; Mifepristone; Neoplasms; Palliative Care; Pancreatic Neoplasms; Receptors, Progesterone; Survival Rate; Thymus Neoplasms; Treatment Outcome; Young Adult | 2010 |
Adenoviral-induced islet cell cytotoxicity is not counteracted by Bcl-2 overexpression.
Topics: Adenoviridae; Animals; Apoptosis; Blotting, Western; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Cytokines; Flow Cytometry; Gene Expression; Genetic Vectors; Hormone Antagonists; In Vitro Techniques; Insulinoma; Islets of Langerhans; Membrane Potentials; Microscopy, Electron; Mifepristone; Mitochondria; Pancreatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Rats; Transfection; Uncoupling Agents | 2002 |
Glucocorticoid receptor concentration modulates glucocorticoid-regulated gene expression in rat pancreatic AR42J cells.
Topics: 1-Methyl-3-isobutylxanthine; Amylases; Animals; Blotting, Western; Dexamethasone; Down-Regulation; Gene Expression; Glucocorticoids; Hormone Antagonists; Mifepristone; Pancreatic Neoplasms; Phosphodiesterase Inhibitors; Rats; Receptors, Bombesin; Receptors, Glucocorticoid; RNA, Messenger; Tumor Cells, Cultured | 1996 |
Dexamethasone regulates the expression of neuronal properties of a rat insulinoma cell line.
Topics: Animals; Cell Differentiation; Cell Line; Chloramphenicol O-Acetyltransferase; Dexamethasone; Gene Expression; Glucocorticoids; Insulinoma; Intermediate Filament Proteins; Kinetics; Mifepristone; Neurons; Pancreatic Neoplasms; Promoter Regions, Genetic; Rats; Receptors, Nerve Growth Factor; Recombinant Proteins; RNA, Messenger; Time Factors; Transfection; Tumor Cells, Cultured | 1995 |
Dexamethasone pretreatment of rat insulinoma cells decreases binding of glucagon-like peptide-1(7-36)amide.
Topics: Animals; Cyclic AMP; Dexamethasone; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucocorticoids; Insulinoma; Mifepristone; Pancreatic Neoplasms; Peptide Fragments; Peptides; Protein Binding; Rats; Time Factors; Tumor Cells, Cultured | 1990 |